Free tool
FAERS Monitor: Rimso-50
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 017788 or its brand name (Rimso-50, Dimethyl Sulfoxide). Reports on generic versions are filed under their own applications.
Reports
243
Serious
198
81% of reports
Hospitalization
82
Death reported
31
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- drug ineffective49
- headache48
- nausea48
- off label use42
- abdominal pain41
- pain39
- pyrexia39
- dyspepsia28
- fatigue28
- constipation27
- infusion related reaction27
- malaise27
- weight decreased26
- anaemia25
- erythema25
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 4 |
| 2005 | 6 |
| 2006 | 2 |
| 2007 | 2 |
| 2008 | 5 |
| 2009 | 12 |
| 2010 | 4 |
| 2011 | 10 |
| 2012 | 3 |
| 2013 | 1 |
| 2014 | 3 |
| 2015 | 15 |
| 2016 | 4 |
| 2017 | 19 |
| 2018 | 14 |
| 2019 | 21 |
| 2020 | 16 |
| 2021 | 18 |
| 2022 | 21 |
| 2023 | 28 |
| 2024 | 10 |
| 2025 | 15 |
| 2026 | 10 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,053,916 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| infusion related reactionSignal | 27 | 35.3 | 24.7 | 867 |
| dyspepsiaSignal | 28 | 24.6 | 17.4 | 614 |
| abdominal painSignal | 41 | 15.3 | 11.5 | 538 |
| anaemiaSignal | 25 | 11.3 | 7.8 | 228 |
| constipationSignal | 27 | 10.7 | 7.5 | 231 |
| erythemaSignal | 25 | 10.5 | 7.3 | 208 |
| pyrexiaSignal | 39 | 9.8 | 7.3 | 303 |
| weight decreasedSignal | 26 | 8.1 | 5.6 | 156 |
| headacheSignal | 48 | 6.6 | 5.1 | 231 |
| painSignal | 39 | 5.5 | 4.1 | 143 |
| malaiseSignal | 27 | 5.3 | 3.7 | 93 |
| nauseaSignal | 48 | 5.2 | 4.1 | 167 |
| off label useSignal | 42 | 4.2 | 3.2 | 102 |
| drug ineffectiveSignal | 49 | 3.2 | 2.5 | 78 |
| fatigueSignal | 28 | 3.1 | 2.2 | 40 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.